Valuation: Stereotaxis, Inc.

Market Cap 84.49M 76.57M 70.82M 63.9M 120M 7.97B 125M 851M 337M 4.26B 317M 310M 13.51B P/E 2026 *
-3.67x
P/E 2027 * -5.06x
Enterprise Value 84.49M 76.57M 70.82M 63.9M 120M 7.97B 125M 851M 337M 4.26B 317M 310M 13.51B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.1x
Free-Float
84.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.80%
1 week-22.64%
Current month-2.25%
1 month-19.70%
3 months-38.90%
6 months-56.54%
Current year-63.34%
1 week 0.8
Extreme 0.8
1.22
1 month 0.8
Extreme 0.8
1.22
Current year 0.8
Extreme 0.8
2.86
1 year 0.8
Extreme 0.8
2.86
3 years 0.8
Extreme 0.8
3.59
5 years 0.8
Extreme 0.8
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 02/02/2017
Director of Finance/CFO 57 30/09/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 31/01/2005
Chairman - 02/02/2017
Director/Board Member 71 28/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-22.64%-62.02%-40.62% 84.49M
+0.11%+0.79%+21.00%+52.47% 259B
+0.37%+1.20%+5.34%+14.49% 164B
+0.84%-2.03%-19.28%+52.11% 154B
+0.32%+3.72%-56.82%-17.92% 64.27B
+1.28%+4.91%+24.16%+62.87% 61.61B
+0.34%-1.59%+0.18%-11.25% 53.94B
+0.55%-0.46%+18.49%+55.86% 49.04B
-0.29%-0.72%+2.78%+73.84% 48.82B
-0.42%+0.58%+21.31%+77.93% 45.24B
Average +0.23%-1.62%-4.49%+31.98% 90B
Weighted average by Cap. +0.37%+0.57%+3.56%+39.97%

Financials

2026 *2027 *
Net sales 31.63M 28.67M 26.51M 23.92M 45.08M 2.98B 46.67M 319M 126M 1.59B 119M 116M 5.06B 40.2M 36.43M 33.69M 30.4M 57.29M 3.79B 59.31M 405M 160M 2.02B 151M 148M 6.43B
Net income -23.13M -20.96M -19.39M -17.49M -32.97M -2.18B -34.13M -233M -92.36M -1.17B -86.81M -84.97M -3.7B -17.27M -15.65M -14.47M -13.06M -24.61M -1.63B -25.48M -174M -68.94M -870M -64.8M -63.42M -2.76B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
13/11/26 US$0.8432 -0.80% 1,609,105
12/11/26 US$0.8500 -5.56% 1,515,002
11/11/26 US$0.9000 -12.62% 3,162,032
10/11/26 US$1.030 -9.65% 817,949
09/11/26 US$1.140 +4.59% 899,583
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8432USD
Average target price
2.667USD
Spread / Average Target
+216.26%
  1. Stock Market
  2. Stocks
  3. STXS Stock